Journal for ImmunoTherapy of Cancer (Nov 2021)
485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors
- Thomas Davis,
- Jessica Price,
- Mark Awad,
- Ammar Sukari,
- Roger Cohen,
- Mark Stein,
- Przemyslaw Twardowski,
- Jessica Flechtner,
- Melissa Johnson,
- Maura Gillison,
- Rudy Lackner,
- Arthur DeCillis,
- Richard Hernandez,
- Kevin Mancini,
- Mara Shainheit,
- Gabriella Santone,
- Syukri Shukor,
- Ece Bicak,
- Vijetha Vemulapalli,
- Emily Tjon
Affiliations
- Thomas Davis
- Aff3 grid.417695.8Celldex Therapeutics, Inc. Charlottesville VA USA
- Jessica Price
- MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, University of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa
- Mark Awad
- Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
- Ammar Sukari
- Aff238 grid.254444.70000000114567807Karmanos Cancer Institute Detroit MI USA
- Roger Cohen
- Aff452 grid.25879.310000000419368972University of Pennsylvania Philadelphia PA USA
- Mark Stein
- Aff293 grid.430387.b0000000419368796Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
- Przemyslaw Twardowski
- Aff5 grid.410425.60000000404218357City of Hope Duarte CA USA
- Jessica Flechtner
- Aff1 grid.475330.60000000405579162Genocea Biosciences, Inc Cambridge MA USA
- Melissa Johnson
- 3Sarah Cannon Research Institute, Nashville, TN, USA
- Maura Gillison
- 2MD Anderson Cancer Center, Houston, TX, USA
- Rudy Lackner
- 6University of Nebraska, Omaha, NE, USA
- Arthur DeCillis
- 7Genocea Biosciences, Centreville, MD, USA
- Richard Hernandez
- 7Genocea Biosciences, Centreville, MD, USA
- Kevin Mancini
- 7Genocea Biosciences, Centreville, MD, USA
- Mara Shainheit
- 7Genocea Biosciences, Centreville, MD, USA
- Gabriella Santone
- Genocea Biosciences, Cambridge, MA, USA
- Syukri Shukor
- Genocea Biosciences, Cambridge, MA, USA
- Ece Bicak
- Genocea Biosciences, Cambridge, MA, USA
- Vijetha Vemulapalli
- 8Genocea, Madison, CT, USA
- Emily Tjon
- 8Genocea, Madison, CT, USA
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.485
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.